David A. Siegel Allakos Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Allakos Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 35,100 shares of ALLK stock, worth $47,385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,100
Previous 30,500
15.08%
Holding current value
$47,385
Previous $38,000
7.89%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ALLK
# of Institutions
96Shares Held
70.7MCall Options Held
43.8KPut Options Held
1.4K-
Bvf Inc San Francisco, CA16.6MShares$22.3 Million0.51% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$8.3 Million0.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$6.75 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.74 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.42MShares$4.62 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $114M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...